ARK Invest Passive

ARK Israel Innovative Technology ETF

The ARK Israel Innovative Technology ETF (“Fund”) seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index (“Index”).

$29.32

Key Metrics

TER 49.00% per year
Distribution policy Distributing
Fund size USD 141 M
Inception date December 5, 2017
Holdings 65
Fund currency USD
Fund domicile US
Provider ARK
For full official fund details, factsheets, and holdings, visit ark-funds.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
ARK Israel Innovative Technology ETF IZRL
Fund Size
$141M
Dividend
2.6%
Fees
49.00%
ARK Innovation ETF ARKK
Fund Size
$6.69B
Dividend
-
Fees
75.00%
ARK Autonomous Technology & Robotics ETF ARKQ
Fund Size
$2.06B
Dividend
0.2%
Fees
75.00%
ARK Next Generation Internet ETF ARKW
Fund Size
$1.84B
Dividend
1.6%
Fees
76.00%
ARK Genomic Revolution ETF ARKG
Fund Size
$1.27B
Dividend
-
Fees
75.00%
View 9 similar ETFs →

Historical Return

Last updated: Jun 15, 2026
1 Year +21.5% +2.6% Div
3 Years (avg.) +15.6% +2.6% Div
5 Years (avg.) -0.7% +2.6% Div

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

21.91% 1 Year
22.24% 3 Years
24.23% 5 Years
24.82% 10 Years

Max Drawdown

-18.27% 1 Year
-24.60% 3 Years
-53.37% 5 Years
-60.11% 10 Years

Sharpe Ratio

0.71 1 Year
0.54 3 Years
-0.09 5 Years
0.14 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026
2017 2018 2019 2020 2021 2022 2023 2024 2025
2017 1.7% -4.7% 2.0% 8.7% 6.1% -3.5% -1.4% 0.6% 3.6%
2018 -10.7% 2.1% 11.2% 7.2% -4.5% -1.9% 0.5% 3.9%
2019 16.8% 24.0% 14.0% -2.8% -0.1% 2.5% 6.2%
2020 31.6% 12.6% -8.6% -3.9% -0.2% 4.5%
2021 -3.7% -23.9% -13.4% -6.8% -0.2%
2022 -39.8% -17.9% -7.9% 0.6%
2023 11.9% 14.0% 19.5%
2024 16.1% 23.4%
2025 31.2%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%
33%
1y 3y N/A N/A
0 - 5%
2%
1y 3y N/A N/A
5 - 10%
36%
1y 3y N/A N/A
10 - 15%
2%
1y 3y N/A N/A
15 - 20%
12%
1y 3y N/A N/A
20 - 30%
7%
1y 3y N/A N/A
30 - 40%
2%
1y 3y N/A N/A
> 40%
4%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
34%
1y 3y N/A N/A
0 - 10
11%
1y 3y N/A N/A
10 - 15
13%
1y 3y N/A N/A
15 - 20
4%
1y 3y N/A N/A
20 - 25
9%
1y 3y N/A N/A
25 - 35
7%
1y 3y N/A N/A
35 - 50
4%
1y 3y N/A N/A
> 50
18%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
15.6%
1y 3y N/A N/A
Small Cap
53.3%
1y 3y N/A N/A
Mid Cap
17.1%
1y 3y N/A N/A
Large Cap
14.0%
1y 3y N/A N/A
Mega Cap
0.0%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jun 15, 2026
11.9% Top 5 Holdings
23.2% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
INMD Inmode Ltd
2.4%
GILT Gilat Satellite Networks
2.4%
TSEM Tower Semiconductor Ltd.
2.4%
MDWD MediWound Ltd
2.3%
TEVA Teva- Pharmaceutical Industries Ltd.
2.3%

Latest News

almost 2 years ago • zacks.com

TEVA's Ajovy Meets Goal in Migraine Prevention Study for Kids

TEVA achieves the primary efficacy endpoint with statistical significance in the phase III study of its marketed drug, Ajovy, for the prevention of...

almost 2 years ago • prnewswire.com

Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd.

almost 2 years ago • globenewswire.com

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs)

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $5.22B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.44% 2.03%
Beta Indicates the relationship between the price performance of a share and the market. 0.98 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 39.0 28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -48.2 -
Profitable Companies 65% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 29.91 14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.22 8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.27 10.72
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 15.21 21.15
Enterprise Value to Revenue Enterprise value divided by revenue 4.84 8.72
Total Debt to Enterprise Value Total debt divided by enterprise value 0.15 0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.33 0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 0.12% -6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -0.3% -117.9%
Return on Equity Equity divided by market cap. 4.43% 1.23%
Return on Assets Indicates a company's profitability in relation to its total assets. -1.63% 3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -0.64% 3.31%

Sectors

Manufacturing 33.2%
Information 20.7%
Professional, Scientific, and Technical Services 4.6%
Health Technology 1.6%
Finance and Insurance 1.6%
Technology Services 1.5%
Educational Services 1.5%
Other 35.4%

Countries

Israel 88.2%
United States 10.1%
Other 1.7%

Stock Screener

Select filters to narrow down the 48 investments below

48 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $814.84M
P/E Ratio 9.7
Dividends 0.0%
Total Investment $2.48M
Weight 1.75%

Loading details…

Market Cap $841.55M
P/E Ratio 25.4
Dividends 0.0%
Total Investment $2.45M
Weight 1.73%

Loading details…

Market Cap $32.05B
P/E Ratio 130.8
Dividends 0.0%
Total Investment $2.44M
Weight 1.72%

Loading details…

Market Cap $154.68M
P/E Ratio -7.0
Dividends 0.0%
Total Investment $2.36M
Weight 1.67%

Loading details…

Loading details…

Market Cap $18.29B
P/E Ratio 68.6
Dividends 0.0%
Total Investment $2.33M
Weight 1.65%

Loading details…

Loading details…

Market Cap $0
P/E Ratio 23.2
Dividends 6.4%
Total Investment $2.29M
Weight 1.62%

Loading details…

Market Cap $1.64B
P/E Ratio -12.6
Dividends 0.0%
Total Investment $2.27M
Weight 1.60%

Loading details…

Market Cap $675.68M
P/E Ratio 64.6
Dividends 0.0%
Total Investment $2.26M
Weight 1.60%

Loading details…

Market Cap $421.69M
P/E Ratio 21.2
Dividends 3.4%
Total Investment $2.26M
Weight 1.60%

Loading details…

Market Cap $1.3B
P/E Ratio 21.6
Dividends 4.6%
Total Investment $2.25M
Weight 1.59%

Loading details…

Market Cap
P/E Ratio 0.0
Dividends
Total Investment $2.25M
Weight 1.59%

Loading details…

Market Cap $8.99B
P/E Ratio 187.7
Dividends 0.0%
Total Investment $2.25M
Weight 1.59%

Loading details…

Market Cap $36.92B
P/E Ratio 61.9
Dividends 0.4%
Total Investment $2.24M
Weight 1.58%

Loading details…

Market Cap $1.33B
P/E Ratio -4.5
Dividends 11.5%
Total Investment $2.22M
Weight 1.57%

Loading details…

Market Cap $1.17B
P/E Ratio 59.6
Dividends 0.0%
Total Investment $2.21M
Weight 1.56%

Loading details…

Market Cap $1.31B
P/E Ratio 12.6
Dividends 1.4%
Total Investment $2.21M
Weight 1.56%

Loading details…

Market Cap $613.23M
P/E Ratio -206.5
Dividends 0.0%
Total Investment $2.18M
Weight 1.54%

Loading details…

Market Cap $10.02B
P/E Ratio -156.4
Dividends 0.0%
Total Investment $2.17M
Weight 1.53%

Loading details…